loader
Please Wait
Applying Filters...

Annual Sales of Benidipine reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 2,139Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Coniel

PharmaCompass

01

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 30

2019 Revenue in Millions : 38

Growth (%) : -20

blank

02

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 23

2020 Revenue in Millions : 30

Growth (%) : -16

blank

03

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 15

2021 Revenue in Millions : 23

Growth (%) : -34

blank

04

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 10

2022 Revenue in Millions : 15

Growth (%) : -25

blank

05

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 60

2016 Revenue in Millions : 73

Growth (%) : -17

blank

06

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 43

2017 Revenue in Millions : 57

Growth (%) : -24%

blank

07

Brand Name : Coniel

Benidipine

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Coniel

arrow
Boulder Peptide 2024
Not Confirmed

Benidipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 37

2018 Revenue in Millions : 45

Growth (%) : -17

blank